Furthermore, the tumor suppressing function of miR-107 has been previously reported in HCC via targeting oncogenic genes, including RGS4, HMGA2, HMGCS2, cofilin-1, and Wnt/β-catenin [39–43]. The gene discussed is RGS4; the disease is neoplasm.